PMC10461623_01
(A) Interstitial glucose values assessed through flash glucose monitoring during three consecutive days with nutritional approach alone. (B) Interstitial glucose values assessed through flash glucose monitoring during three consecutive days with nutritional approach plus 300-mg canagliflozin treatment.
fendo-14-1193696-g001.jpg
PMC10461623_01_fendo-14-1193696-g001.jpg
f1
The main FGM metrics referring to the three consecutive days with nutritional approach alone and to the three consecutive days following the addition of canagliflozin are reported in  Figures 1A, B .